These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 17534685)
1. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Foroulis CN; Thorpe JA Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389 [TBL] [Abstract][Full Text] [Related]
3. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus. Gray J; Fullarton GM Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112 [TBL] [Abstract][Full Text] [Related]
4. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. Gossner L; May A; Sroka R; Ell C Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Wolfsen HC; Woodward TA; Raimondo M Mayo Clin Proc; 2002 Nov; 77(11):1176-81. PubMed ID: 12440553 [TBL] [Abstract][Full Text] [Related]
8. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665 [TBL] [Abstract][Full Text] [Related]
9. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M; Gastrointest Endosc; 2005 Oct; 62(4):488-98. PubMed ID: 16185958 [TBL] [Abstract][Full Text] [Related]
11. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Panjehpour M; Overholt BF Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma. Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964 [TBL] [Abstract][Full Text] [Related]
13. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer]. Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391 [TBL] [Abstract][Full Text] [Related]
14. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Prasad GA; Wang KK; Buttar NS; Wongkeesong LM; Lutzke LS; Borkenhagen LS Gastrointest Endosc; 2007 Jan; 65(1):60-6. PubMed ID: 17185080 [TBL] [Abstract][Full Text] [Related]
15. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. Yachimski P; Puricelli WP; Nishioka NS Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764 [TBL] [Abstract][Full Text] [Related]
16. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M; Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436 [TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus. Dunn JM; Mackenzie GD; Banks MR; Mosse CA; Haidry R; Green S; Thorpe S; Rodriguez-Justo M; Winstanley A; Novelli MR; Bown SG; Lovat LB Lasers Med Sci; 2013 May; 28(3):707-15. PubMed ID: 22699800 [TBL] [Abstract][Full Text] [Related]
18. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Panjehpour M; Overholt BF; Haydek JM; Lee SG Am J Gastroenterol; 2000 Sep; 95(9):2177-84. PubMed ID: 11007214 [TBL] [Abstract][Full Text] [Related]